Professional Documents
Culture Documents
2018
1
Executive Summary
The Expanded Program on Immunization (EPI) is a health intervention
program designed by World Health Organization (WHO) in response to
the high infant morbidity and mortality due to infectious diseases. WHO
recommends immunization strategies to all countries through EPI program.
Indonesia had committed and adopted the goal of measles elimination and
rubella/CRS control in South East Asia Region by 2020. Mass vaccination
campaigns are considered an important strategy to increase vaccine coverage.
MR campaign had been done in all provinces in Java Island (West Java,
Banten, DKI Jakarta, DI Yogyakarta, Central Java and East java) on
A u g u s t - September 2017. In 2018 the MR campaign will be conducted for
all provinces out of Java Island for all rest of provinces in Indonesia.
However, before the MR campaign out Java island, evaluation of MR
campaign in Java island may be conducted in order to know the real MR
immunization coverage in the population and the obstacles during MR
campaign in the field at all provinces at Java Island. This study using cross
sectional study design combine between quantitative (province coverage
survey) and qualitative approach (Rapid Assessment Procedure (RAP). The
survey (coverage survey) using WHO followed WHO manual for
Immunization Coverage Survey 2015 to describe immunization coverage
in DIY Province. The qualitative approach will used in-depth interview,
observation and secondary data collection in order to know the obstacles
during MR campaign at DIY Province. The coverage evaluation survey will
help better plan for the MR campaign in the rest of Indonesia scheduled for
2018.
2
1. Introduction
1.1 Backgrounds
The current epidemiology of measles and rubella in Indonesia reflects the progress
and challenges of the immunization program over time. Although immunization
against measles began more than 30 years ago, measles remained endemic until
recently.
Measles and rubella are vaccine preventable, viral diseases that have the potential to
harm non-immune pregnant women and their fetuses/neonates if exposure occurs.
The most concerning of these is rubella, as it can cause congenital rubella syndrome
(CRS) with devastating effects. Measles has long been a recognized public health
problem in Indonesia, but the burden of rubella and congenital rubella syndrome
(CRS) has been underappreciated until recently. 1–3
Measles and rubella are among the most infectious diseases of humans. High level of
herd immunity is required for its elimination. Sero-prevalence studies suggest that
coverage in the range of 90–95 % is needed. Measles and rubella are vaccine-
preventable diseases with similar symptoms and are frequently confused with each
other. Both viruses cause rash and fever. Measles can be deadly for children with
poor nutrition and weakened immune systems. Rubella is also very contagious but
causes relatively mild disease in children; in pregnant women, rubella can lead to
miscarriage or severe birth defects (congenital rubella syndrome), including
blindness, deafness, and heart problems. Rubella and measles are a public health
problem in poor countries in Africa and Asia, including Indonesia, where uptake of
the measles and rubella vaccine is relatively low and increasing access to
immunization through large scale vaccination campaigns can significantly reduce
deaths and illnesses.4–6
3
The Expanded Program on Immunization (EPI) is a health intervention program
designed by World Health Organization (WHO) in response to the high infant
morbidity and mortality due to infectious diseases. WHO recommends immunization
strategies to all countries through EPI program. Immunization of infants with
measles vaccine, tetanus toxoid, hepatitis B vaccine, OPV for Poliomyelitis and DTP
for diphtheria, pertussis, and tetanus are recommended to all countries. Indonesia
had been implementing basic immunization as national immunization program
formally since 1979. 7
Several aims will be adressed to adopt the goal of measles elimination and
rubella/CRS control in South Eash Asia Region by 2020, such as achieve and
maintain at lease 95% population imunity with two dose againts measles and rubella
within each district of each country in region through routine/or supplementary
immunization, develop and sustain and timely case-based measles and rubella and
CRD surveillance sysstem in each country in the region that fulfils recommended
surveillance performance indicators, develop and maintain a WHO proficient
measels and rubella laboratory network that support every country in the region,
strengthen support and linkages to achieve the above three strategic objectives. 9–11
Indonesia had commited and adopted the goal of measles elimination and
rubella/CRS control in South Eash Asia Region by 2020. In order to achive measles
elimination by the year 2020 some activities will be done, which are:12–14
1. Indonesia has national measles elimination and rublella/CRS control by 2020
by conducting some objectives,which are: i)first dose measles coverage at leas
4
95% nationally and >90% subnational by 2018. ii) second dose vacinnation
coveage at least 95% in 2018
2. Measles campaign at high risk areas at the end of 2016 targeting children 9-59
month National MR Campaign in 2018- 2019 targeting 9 month – 15 years
3. Fully investigated all detected/reported measles outbreaks
4. Case based measles surveillance :
▪ 50% specimens tested by 2016 • 100 % specimen tested by 2020
5. CRS Surveillance initiated at selected hospital in 10 provinces in 2015 and
will be expanded to the remaining provinces in 2017 - 2019
MR campaign had been done in all provinces in Java island (West Java, Banten,
DKI Jakarta, DI Yogyakarta, Central Java and East java) on September 2017. In
2018 the MR campaign will be conducted for all provinces out of Java Island for all
rest of provinces in Indonesia. 8
5
Rubella cases from 2016 to 2017 in DIY Province. The case of Rubella disease in
the Province of Yogyakarta has increased from 2016 cases by 486 cases (22%) from
2196 suspect to 789 cases (32%) from 2288 suspect in 2017. The highest case
increase occurred in Gunung Kidul District, which was 291 cases (61%) in 2017
originally in 2016 only 50 cases (17%).
MR immunization coverage 98.6% ( 760,145 immunized from 771,288 population
target). MR vaccination coverage in Kulon Progo, Gunung Kidul, Yogyakarta,
Sleman, and Bantul were 99.1%, 99.3%, 98.2%, 98.3%, and 98.3% respectively.
Main factor of MR immunization rejection is religion ( 3,243 cases). There were 4
AEFI cases validated by National Commision of AEFI.
1.2 Objectives
1.2.1 General Objectives
To determine provincial MR immunization coverage among children 9 month to 15
years old at the time of the 2017 campaign in the community at DIY Province and to
know the several challenges of MR campaign in the field in order to report the
progress to date made toward measles and rubella elimination in Indonesia and the
implementation and results of measles–rubella (MR) vaccination campaigns
conducted in 2017 had a significant impact on measles and rubella cases.
6
In other words, to assess the impact of the measles rubella campaign activities on
improving population-level vaccine coverage, identify sub-group with lower
coverage, estimate coverage rates by subgroups, and identify reasons for vaccine
noncompliance or refusal.
Specific Objectives
i. Assess SIA MR Vaccination coverage by sex, rural/urban, length of residency
in the area and other demographic characteristics.
ii. Assess factors related to not receiving an MR vaccine during SIA
iii. Assess the proportion of children with zero MCB vaccination, the proportion
for whom the SIA vaccination was their first MCV and the proportion with at
least 1 and at least 2 MCV doses by age group.
iv. Assess the occurence of AEFI, systemic and local reactions, and those that
require medical consultation.
v. Have a qualitative assessment of the campaign among health workers, school,
and the community.
vi. Assess vaccination card (for RI) ever received and available.
The MR campaign in Java island was done at on September to October 2017. The
survey will be conducted on 20 June-31 August 2018.
7
1.5 The Location of Survey
The immunization coverage survey will be conducted in DIY Province. The results
of the survey will reflect the immunization coverage of MR immunization coverage
for it. The study will be located at DIY Province.
1.6 Organization
The survey will be organized by Public Heath Faculty of Diponegoro University at
Central Java province.
1.8 Budget
Budget for the studies funded by WHO Indonesia collaborated with National
EPI program Center for Diseases Control MoH RI.
8
II. Conceptual Assessment andVariables
Enabling Factors
- Vaccines avaibility Providers Immunization Quality of
- Access Services
- Quality of - Place of Services
imm.services - Skill of HP
- Logistic, etc
- etc
Reinforcing Factors
- Family support Immunization Program
- Community - Policy on Practices
support - MR Imunization
- HP support - Obstacles and
Challenges
- etc
Threat
- Side Effects
- Norms
- Religions values
Immunization Status
(coverage)
• MR immunization
Figure 2.1. Conceptual Framework
9
Based on the conceptual framework above, the immunization status of the children
affected by two factors which are: i) the children factors and ii)providers factors.
The children factors will be depended on four factors: predisposing, enabling,
reinforcing, and threat. Where the providers factors will be depended on: resource
and management, quality of immunization services and policy and obstacles in the
field during MR campaign. Predisposing factors include age, education,
employment, socioeconomic, KAP. Enabling factors include availability of vaccines,
access to health services, quality of immunization services. Reinforcing factors
include family support, community support, and HP support. While threat include
side effects, norms, and religious values. Where the providers factors will be
depended on: resource and management, quality of immunization services and
policy and obstacles in the field during MR campaign. In addition to a direct
relationship between encoded exposure and MR vaccination, it is plausible that
indirect effects occurred through HBM variables targeted by the campaign. The
HBM posits that people will take action to prevent illness if they regard themselves
as susceptible to a condition (perceived susceptibility). This refers to a person's
subjective perception of the risks of his or her health condition. In the case of
medical illness, these dimensions include acceptance of the diagnosis, personal
estimation of the presence of resusceptibilily, and susceptibilily to disease in
general.
If they believe it would have potentially serious consequences (perceived severity).
Feelings about the seriousness of a disease include the evaluation of clinical and
medical consequences (for example, death, disability, and illness) and possible
social consequences (such as effects on work, family life, and social relations).
If they believe that particular course of action available to them would reduce the
susceptibility or severity or lead to other positive outcome (perceived benefits). This
encourages to produce a supportive force toward behavioral change. This depends
on one's belief in the effectiveness of the various measures available in reducing the
threat of illness, or perceived benefits in taking such health endeavors.
But if they perceive few negative attributes related to the health action (perceived
barriers). Additionally, the belief that one can successfully complete the behavior of
10
interest despite considered barriers (self-efficacy). However, in actuality, self-
efficacy is rarely included in HBM studies. Although less investigated, the model
also suggests that specific cues, such as factors in one’s environment, can impact the
final action one takes regard to the action in immunization. These cues to action can
be internal or external, ranging from experiencing symptoms of an illness to
exposure to a campaign. Much like self-efficacy, cues to action have not been
systematically evaluated, particularly considering their often fleeting nature.22–24
2.3.1. Variables
MR Immunization Status
• Status of MR immunization of children 9 months to less than 15 years old
during MR Campaign in Java island
Immunization Program
• Policy in immunization program practices at local areas
• Organization and the man power
• Obstacles in immunization program
11
• Management of cold chains and logistics
• Recording and reporting of immunization
Quality of Services
• Process in immunization program services
• Place of services
• Skill of heath personels
• Hospitality of health personels
• Cost of services
Predisposing Factors
• Age of parent
• Education attainment of parent
• Knowledge, attitudes and practices (KAP) of parentmother or caregiver
• Social Economic, etc
Enabling Factors
• Vaccines avaibility
• Access
• Quality of imm.services
Reinforcing Factors
• Parent support
• Community support
Threat
• Side Effects Experiences
• Norms and Cultures
• Religions values
• Access
12
• Working mother
• Parental knowledge on Immunization benefit
13
III. Methods
This study using cross sectional study design combine between quantitative
(province coverage survey) and qualitative approach (Rapid Assessment Procedure
(RAP)). The survey (coverage survey) using WHO followed WHO manual for
Immunization Coverage Survey 20151 to describe immunization coverage in the
study areas. The qualitative approach will used indepth interview, observation and
secondary data collection in order to know the obstacles during MR campaign in
province level and among health workers in districts.
Both quantitative and qualitative evaluations were done after implementation of the
campaign. Quantitative data were presented with mean (standard deviation, SD) for
continuous variables and with proportion for categorical variables. The overall and
age- and sex-specific coverage rates were calculated for each region and then
combined. Categorical variables were compared by chi-square statistics. Multiple
logistic regression analysis were performed to estimate odds ratios (OR) and 95 %
confidence intervals (CI) of coverage associated with covariates, with adjustment for
other covariates. Qualitative data were analyzed using content analysis.
11
WHO, Immunization Coverage Cluster Survey-Reference manual 2015, Working Draft Updated
July 2015, WHO Document Production Services, Geneva, Switzerland, July 2015
14
not by field teams to avoid selection biases) as recommended by the 2015 WHO
Survey Manual. All selected HHs will be contacted, those with who have children 9
to 59 months of age and 5-15 years old will be selected randomly using ‘random
walk’ both at two strata (urban and rural) in each cluster interviewed. All
probabilities of selection (of clusters, of HHs in each cluster, and of eligible persons
among all those eligible in a HHs) will be collected to allow for calculating design
weights, plus the outcome of each HH visit to correct for non-response. This
information is needed to conduct weighted analysis, to ensure representativeness, as
recommended by the 2015 WHO Vaccination Coverage Survey Manual.
3.2. Location
15
Table. 3.1. Population of Children Less than 15 years old for all Provinces
Provinces Children 0- Children 5- Children Total
4 y.o and 9 years old 10-15 Proportion
below years old CUF/%yo
above
DI 274,200 266,700 262,500
Yogyakarta 803,400 51,8
The samples in the survey are: the children 9-59 months to 15 years old living at the
selected clusters (villages and kelurahan) are the target population from which the
sample will be drawn. Proportion of children underfive compared to children 5 to 15
years old was 51,8%.
In WHO coverage cluster survey manual 2015, sample size may be calculated with
the specific formula of sample size for small proportion since the coverage of MR in
Java islands was more than 95%, therefore the proportion unvaccinated children
because very small, therefore, here the sample size may be calculated using the
formula. 25
By considering urban and rural area in the DIY Province was vary according to MR
coverage, social economic status, education attaintment, etc, therefore in this
16
coverage survey 2 strata (urban and rural) was define in order to anticipate the
variation of urban and rural in DIY Province.
In order to calculate the Effective Sample Size (ESS) the formula from Fleis in
WHO manual for coverage survey is in the following:
ESS does not change for coverage levels between 30% and 70%. When the coverage
level is assumed to lie outside the interval [30%, 70%], then a value of < 1 could
be used to reduce the required effective sample size (see Table B-1 for examples).
Suppose a 2-sided 95% confidence interval is desired with ±6% precision (d = 0.06).
Also suppose that the coverage probability is expected to be around 95%. Using the
value: k = 4(0.95-0.06) (1-0.95+0.06) = 0.3916 by using the formula above then the
Efective Sample Size (ESS) was 131.
WHO also developed the sample calculation using excel software using the formula.
Using the excel software and considering some criterias (conservative considerations
for intracluster correlation (ICC) which relates to the design effect, ) in the sample
calculation this study come up with the results: Total sample (AxBxC) was 875 ,
total number of household to be visited 2,764 household to be visited (NcsxDxE) at
both stratum (urban and rural). Number of household for each statum (BxCxDxE)
was 1,382 household. Number of cluster per stratum 30 (for each urban and rural)
(BxC/m) and number of household per cluster (DxExm) = 48 and total cluster 60
clusters. In order to anticipate non response rate the sample size will be round up to
be 1500 for each strata. As results from both sample size consideration with
probability sampling and sample size with small proportion, then sample size in this
17
study 30 clusters for each strata (urban and rural) and and 50 household in each and
the total sample will be 3000 household.
Among children 12-59 months additional questioners for basic routine immunization
coverage will also be measure in this study. Therefore this population (children 9
months to 59 months) of age will be considered as different strata with children 5-15
years old.. Number sample of those agegroup in each strata will be proportionally in
each province, Therefore the number of sample for agegroup in each strata in each
province in the following Table:
Urban in this coverage survey is all kelurahan (same with village at district)located
at all “cities” in each province. Rural is all villages located at all “districts” at each
province. City and district will be differentiate based on the Central Statistics Office
(BPS) data. Kelurahan and village will also be based on the BPS data in Indonesia.
18
Then all kelurahan will be stratified as urban village and all villages (desa) will be
stratified as rural strata. Thus in each province will be devided in to two group of
strata urban villages and rural village.
19
Provisions were will be made during the sampling with a list of additional desa to
replace sampled village (desa or kelurahan) that could not be surveyed for:
i. Insecurity
ii. Size in the case of very small islands
iii. “Non existence” of the desa (this can happen due to administrative changes
over time)
Any replacement will be well documented.
20
District Subdistrict No Village Number of
Population
6.
Nanggulan Donomulyo 5711
7.
Samigaluh Gerbosari 4109
8.
Kretek Tirtomulyo 6449
9.
Bantul Bantul 15587
10.
Imogiri Imogiri 3727
BANTUL
11.
Pleret Wonokromo 13404
12.
Banguntapan Tamanan 12954
13.
Kasihan Tirtonirmolo 23874
14.
Panggang Girikarto 3648
15.
Paliyan Pampang 2325
16.
Tepus Sumber wungu 5559
17.
Rongkop Pucanganom 3439
18.
Semanu Semanu 14931
GUNUNG 19.
KIDUL Karangmojo Bejiharjo 12532
20.
Wonosari Siraman 5343
21.
Playen Dengok 2271
22.
Patuk Nglegi 2766
23.
Gedang sari Serut 4828
24.
Ngawen Tancep 5539
25.
Moyudan Sumber agung 10724
26.
Godean Sidoluhur 9466
27.
Mlati Tlogoadi 11884
SLEMAN
28.
Prambanan Sambi rejo 5097
29.
Ngaglik Sinduharjo 19168
30.
Tempel Pondok rejo 5529
21
Table 3.5 Randomly Selected Kelurahan in DIY Province (Urban Areas)
District Subdistrict No Village Number of
Population
1.
Mantrijeron Gedongkiwo 12334
2.
Mantrijeron Mantrijeron 8719
3.
Kraton Panembahan 7328
4.
Kraton Kadipaten 5472
5.
Mergangsan Keparakan 8696
6.
Mergangsan Wirogunan 10937
7.
Umbulharjo Sorosutan 16012
8.
Umbulharjo Warungboto 11541
9.
Umbulharjo Tahunan 9834
10.
Umbulharjo Semaki 5271
11.
Kotagede Prenggan 10694
12.
Kotagede Purbayan 8973
13.
Kotagede Rejowinangun 11485
YOGYAKARTA Gondokusuman 14.
Baciro 12603
15.
Gondokusuman Klitren 10320
16.
Gondokusuman Kotabaru 2518
17.
Danurejan Suryatmajan 4266
18.
Danurejan Tegal panggung 7760
19.
Pakualaman Purwo kinanti 5186
20.
Pakualaman Gunung ketur 4130
21.
Gondomanan Ngupasan 4787
22.
Ngampilan Notoprajan 7468
23.
Wirobrajan Patangpuluhan 6172
24.
Wirobrajan Wirobrajan 9247
25.
Gedong tengen Pringgokusuman 10859
26.
Gedong tengen Sosromenduran 6326
27.
Jetis Gowongan 6656
22
District Subdistrict No Village Number of
Population
28.
Jetis Cokrodiningratan 7857
29.
Tegalrejo Bener 4916
30.
Tegalrejo Kricak 12393
by simple random sampling from the llist of children under five and children 5-15
y.o. Or if the list not availabe random selection will be selected randomly by range
or interval that will be deetermined based on number of children under five and
children 5-15 y.o available at each selected cluster.
3.6. Selection of Respondents
Any of the following household residents were eligible for inclusion in the survey:
▪ Having children 9-59 months of age and children 5-<15 years old.
▪ Mother and caregiver of children is willing to be interviewed
23
the first visit, field team will make up to once more visits to meet them. If a
respondent is present at the first visit but the home-based record (for routine
vaccination) is not available, then field team will complete as much of the
questionnaire as possible at the first visit and do up to two more visits to review the
home-based record and complete the relevant section of the questionnaire. A ‘mop
up’ revisit is also planned to be conducted on weekends and holidays, especially in
the urban areas.
B. Qualitative Approach
3.9. Data Collection Methods
24
Table 3.4. Key Informants and Data Collection Methods
All key informants in province level will be interviewed, however for key
informants in district level, health centers and village will be selected purposively
based on some inlcusson criteria which are
- MR coverage (low, medium and high)
- Problem during MR campaign implementation (hard and low)
- Distance to capital city of province and or district
- Some other related condition to the MR campaign implementation
Respondents in the survey are mothers/care giver whose eligible children were in the
HHs sampled in the survey. The mothers/care giver will be interviewed to gather
information related to the MR immunization status of the children.
25
All key informants at each level will be indepth interviewed regard to obstacles of
MR immunization during the campaign.
3.11.2. Interviewer
This study will be implemented through collaboration with Public Health Faculty,
Diponegoro University as Government University with DIY Health Province, All
District Health Office and Health Centre. Data collection in the field will be
conducted by Public Health Faculty, Diponegoro University and supervised by the
researchers and DIY Health Province officer. For DIY province 20 interviewers will
be recruited by researchers.
3.11.4. Instruments
26
Indonesia. The field tested will be held before used. The objectives of the field test
are:
• To determine whether the questions are understandably
• To determine whether interviewers understand the questions and instructions
• To determine the time needed to locate an eligible child or mother and the time
needed to gather information for one eligible child.
• To determine whether the team works are working smoothly
• To determine whether data collection tools allow for legible recording of data
as they are collected.
Data will be collected in 30 rural areas and 30 urban areas at DIY Province by
enumerators. Enumerators conducting interview with the mother of the children as
the study sample. Data from each enumerator will be cross-checked by the
supervisors in the field. Any inconsistencies or incomplete information will be dealt
with accordingly before leaving the area. Complete questionnaires will be cleaned
and entered into the computer by data programmers. Data entry will be double
checked by data encoder and data manager. Data analysis will be done for each
provinces, and then collated together as a description of the country.
27
probability) were estimated to compute weighted cover-age rates for each division
and all divisions combined. Data were presented with mean (standard deviation, SD)
for continuous variables and with proportion for categorical variables. The overall
and age and sex-specific coverage rates were calculated for each division and then
combined. Categorical variables were compared by chi square statistics. Multiple
logistic regression analyses were performed to estimate odds ratios (OR) and 95 %
confidence intervals (CI) of coverage associated with covariates, with adjustment for
other covariates. Qualitative data were analyzed using content analysis.
28
Advanced visit to the field will be done by province coordinators to socialize the
survey to the formal and informal community leaders. All enumerator will be trained
before data collection in order to give better understanding to the survey and all
instruments used in the survey.
3.13. Organization
Survey team from Public Health Faculty of Diponegoro University at Central Java.
The survey team will comprise of a team leader (project coordinator), principal
investigator, researchers, field coordinators (provincial and district coordinators),
enumerators, data manager, administration staff, and finance staff. Survey team are
from Faculty of Public Health Diponegoro University. The researcher had trained
in conducting Rapid Coverage Assessment Immunization 2013 held by University
29
of Indonesia and conducting crossectional study to assess cold chain design in
Public Health Centre in 3 District.
The survey team will comprise of a team leader (project coordinator), researchers,
field coordinators, enumerators and data manager.
Consultant : Dr. dr. Tri Ynis Miko Wahyono, M.Sc
Team leader : Lintang Dian Saraswati, SKM, M. Epid
Researcher : Praba Ginandjar, SKM, M. Biomed
Nissa Kusariana, SKM, M.Si
Data Manager : Putri Septyarini, SKM
Field Coordinator : 4 persons (TBD)
Enumerators : 20 persons (TBD)
Finance and Admin : Endang Sri Utami, SKM
Local counterpart : 4 persons (TBD)
Informed Consent will be implemented before interview with all the respondents.
Confidentiality of the data collected will be maintained in each university that
conducted the survey. Identifying personal information will be accessible only to the
essential staff (researchers).
Data will not be used in any publications, reports or media, without any permission
from WHO, National EPI program and researchers due to the survey will be funded
by WHO with collaborated with National EPI program. Hence, all the data and
report will be submitted to WHO and National EPI program who have full authority
to the the data and reports.
Ethical Approvals for the protocol will be submitted to ethical commitee of Public
Health Faculty of Diponegoro University.
IV. References
30
1. Baba K, Okuno Y, Tanaka-Taya K, Okabe N. Immunization coverage and
natural infection rates of vaccine-preventable diseases among children by
questionnaire survey in 2005 in Japan. Vaccine [Internet]. 2011 Apr 5 [cited
2018 Jan 24];29(16):3089–92. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20870055
2. Hisano M, Kato T, Inoue E, Sago H, Yamaguchi K. Evaluation of measles–
rubella vaccination for mothers in early puerperal phase. Vaccine [Internet].
2016 Feb 24 [cited 2018 Jan 24];34(9):1208–14. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/26801065
3. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney
F. Progress in Measles and Rubella Elimination in Iran. Pediatr Infect Dis J
[Internet]. 2007 Dec [cited 2018 Jan 24];26(12):1137–41. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18043452
4. Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook A-O, Theamboonlers
A, Poovorawan Y. Seroprevalence of antibodies to measles, mumps, and
rubella among Thai population: evaluation of measles/MMR immunization
programme. J Health Popul Nutr [Internet]. 2009 Feb [cited 2017 Dec
25];27(1):80–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19248651
5. White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles,
mumps, and rubella. Clin Obstet Gynecol [Internet]. 2012 Jun [cited 2018 Jan
24];55(2):550–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22510638
6. Taneja D, Sharma P. Targeting rubella for elimination. Indian J Public Health
[Internet]. 2012 [cited 2018 Jan 24];56(4):269. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/23354136
7. World Health Organization. Global Programme for Vaccines and
Immunization: Expanded Programme on Immunization: Safe Vaccine
[Internet]. Geneva, Switzerland; 1998. Available from:
http://apps.who.int/iris/bitstream/10665/65204/1/WHO_GPV_98.04.pdf
8. CDC-MOH_RI. Profile of CDC Directorate Performance 2015. Jakarta; 2015.
31
9. Aaby P, Clements CJ. Measles immunization research: a review. Bull World
Health Organ [Internet]. 1989 [cited 2018 Jan 24];67(4):443–8. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/2680141
10. Stambos V, Leydon J, Riddell M, Clothier H, Catton M, Featherstone D, et al.
Evaluation of the World Health Organization Global Measles and Rubella
Quality Assurance Program, 2001–2008. J Infect Dis [Internet]. 2011 Jul
[cited 2018 Jan 24];204(suppl_1):S499–505. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21666206
11. Vashishtha VM, Yewale VN, Bansal CP, Mehta PJ, Indian Academy of
Pediatrics, Advisory Committee on Vaccines and Immunization Practices
(ACVIP). IAP perspectives on measles and rubella elimination strategies.
Indian Pediatr [Internet]. 2014 Sep [cited 2018 Jan 24];51(9):719–22.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25228604
12. Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, et al.
Evaluation of impact of measles rubella campaign on vaccination coverage
and routine immunization services in Bangladesh. BMC Infect Dis [Internet].
2016 Dec 12 [cited 2018 Jan 24];16(1):411. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/27519586
13. Bechini A, Levi M, Boccalini S, Tiscione E, Panatto D, Amicizia D, et al.
Progress in the elimination of measles and congenital rubella in Central Italy.
Hum Vaccin Immunother [Internet]. 2013 Mar [cited 2018 Jan 24];9(3):649–
56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23292174
14. Ihara T. The strategy for prevention of measles and rubella prevalence with
measles–rubella (MR) vaccine in Japan. Vaccine [Internet]. 2009 May 21
[cited 2018 Jan 24];27(24):3234–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19366578
15. Reichler MR, Darwish A, Stroh G, Stevenson J, Al Nasr MA, Oun SA, et al.
Cluster survey evaluation of coverage and risk factors for failure to be
immunized during the 1995 National Immunization Days in Egypt. Int J
Epidemiol [Internet]. 1998 Dec [cited 2018 Jan 24];27(6):1083–9. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/10024208
32
16. Salmaso S, Rota MC, Ciofi Degli Atti ML, Tozzi AE, Kreidl P. Infant
immunization coverage in Italy: estimates by simultaneous EPI cluster
surveys of regions. ICONA Study Group. Bull World Health Organ [Internet].
1999 [cited 2018 Jan 24];77(10):843–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10593033
17. Webber R. Communicable Disease Epidemiology and Control A Global
Perspective [Internet]. 2nd ed. Walingford Oxfordshire : CABI Publishing is a
division of CAB International CABI Publishing; 2005 [cited 2018 Jan 24].
32-74 p. Available from: http://www.harep.org/Agriculture/2005p.pdf
18. Ministry of Health Republic of Indonesia. Indonesia Health Profile, 2016.
Jakarta; 2016.
19. WHO. World Health Organization Vaccination Coverage Cluster Surveys:
Reference Manual [Internet]. Geneva; 2015 [cited 2018 Jan 24]. (version 3
updated July 2015). Available from:
http://www.who.int/immunization/monitoring_surveillance/Vaccination_cove
rage_cluster_survey_with_annexes.pdf
20. Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H,
Celestin E-P. The Use of Rapid Coverage Monitoring in the National Rubella
Vaccination Campaign, Haiti 2007–2008. J Infect Dis [Internet]. 2011 Sep 1
[cited 2018 Jan 24];204(suppl_2):S698–705. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21954269
21. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE,
Chamouillet H, et al. Haiti 2007-2008 National Measles-Rubella Vaccination
Campaign: Implications for Rubella Elimination. J Infect Dis [Internet]. 2011
Sep 1 [cited 2018 Jan 24];204(suppl 2):S616–21. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21954256
22. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the
Health Belief Model. Health Educ Q [Internet]. 1988 [cited 2018 Jan
24];15(2):175–83. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3378902
23. Carpenter CJ. A Meta-Analysis of the Effectiveness of Health Belief Model
33
Variables in Predicting Behavior. Health Commun [Internet]. 2010 Nov 30
[cited 2018 Jan 24];25(8):661–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21153982
24. Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer
BK, Viswanath K, editors. Health Behavior and Health Education: Theories,
Research, and Practice. San Francisco, CA: Jossey Bass; 2008.
25. Lemeshow S. Adequacy of Sample Size in Health Studies. Geneva,
Switzerland: World Health Organization; 1990.
34
Biodata Anggota Peneliti
A. Identitas Diri
1 Nama Lengkap (dengan gelar) Lintang Dian Saraswati, SKM, M.Epid
2 Jenis Kelamin Perempuan
3 Jabatan Fungsional Lektor
4 NIP 198111042003122001
5 NIDN 0004118103
6 Tempat tanggal lahir Karanganyar, 4 November 1981
7 Email lintang.saraswati@live.undip.ac.id,
8 No telpon/HP 0246924422/08122916641
9 Alamat kantor FKM UNDIP, jalan Prof Sudharto SH
Tembalang Semarang
10 No telp/Faks 024760044/0247460044 ekstensi 102
11 Lulusan yang telah dihasilkan S1=80 orang, S2=6 orang, S3=0 orang
12 Mata Kuliah yang diampu 1. Isu Terkini Penyakit Tidak Menular
2. Survailans Kesehatan Masyarakat
3. Epidemiologi Penyakit Menular
4. Penyelidikan Wabah
5. Metodologi Penelitian
6. Metode Epidemiologi
7. Survei Epidemiologi
8. Epidemiologi Penyakit Tidak Menular
9. Dasar Epidemiologi
10. Epidemiologi KIA
B. Riwayat Pendidikan
S1 S2
Nama Perguruan Tinggi Universitas Diponegoro Universitas Indonesia
Bidang Ilmu Kesehatan Masyarakat, Epidemiologi, kekhususan
Peminatan Epidemiologi Epidemiologi Komunitas
Tahun Masuk-Lulus 1999-2003 2006-2008
Judul Peran PSN oleh Dasa Faktor risiko hepatitis kronis
skripsi/thesis/disertasi wisma dalam P3M DBD Pada tenaga kesehatan (studi
di RSDK 2008)
Nama dr. Ari Udijono, M.Kes DR. dr. Ratna Djuwita, MPH
pembimbing/promotor M. Arie Wuryanto, SKM, DR. dr. Tri Yunis Miko, MPH
M.Kes
E. PublikasiArtikelIlmiahDalamJurnalDalam 5 TahunTerakhir
No JudulArtikel NamaJurnal Volume/Nomor/Tahun
1 Prevalens diabetes mellitus dan Kemas Jurnal Kesehatan 2014; 9(2): 106-210
tuberculosis paru Masyarakat.
2 Duration Of Type 2 Dm, Less Kesmas Indonesia Jurnal 2014; 7(1) : 12-21
Physical Activity, Irreguler Ilmiah Kesehatan
Medication, And Diabetic Diet Masyarakat
Non-adherence As Risk Factors (kesmasindo)
Of Chronic Complications
(Study In Type2 Diabetes
Mellitus/Niddm Patients At
Kudus District Hospital).
3 Elimination of Breeding Places Kesmas Indonesia Jurnal 2014; 7(1) :22-30
at School As a control of DHF Ilmiah Kesehatan
in Semarang. Masyarakat
(kesmasindo)
4 Risk assessment of Procedia 2015; 23: 93-98
Drinking Water Supply System Environmental
in the Tidal Inundation Area of Sciences
Semarang
5 Risk factors of hypertension in Makara Journal of Vol 19, No 2 (2015):
menopausal women in Health Research. 517
RejomulyoMadiun
6 Profileofglycated- Biomedical 2016; 39(5):354-360
hemoglobin, antioxidant vitamin Journals
and cytokinelevels in pulmonary
tuberculosis patients: A cross
sectional studyat Pulmonary
Diseases Center Semarang City,
Indonesia
7 Tuberculosis Worsen The Malaysian Journal 2017 (1), 151-156
Nutritional Status Of Hiv of Public Health
Patients If Unsupported By Medicine
Good Nutrition: A Cross
Sectional Study At Pulmonary
Diseases Center Semarang City,
Indonesia
8 The need of adequate IOP Conference Volume55, conf. 1
information to achieve total Series: Earth and http://iopscience.iop.org/ar
compliance of mass drug Environmental Science ticle/10.1088/1755-
administration in Pekalongan 1315/55/1/012059/meta
9 Environmental and Risk Factors IOP Conference Volume55, conf. 1
of Leptospirosis: A Spatial Series: Earth and Http://iopscience.Iop.Org/
Analysis in Semarang City Environmental Science Article/10.1088/1755-
1315/55/1/012013/Meta
10 Comparison Between TB-HIV Advanced Science 2017, 23, pp 3554–3557
Patients and HIV Patients: A Letter http://www.ingentaconnec
Cross-Sectional Study at t.com/contentone/asp/asl/2
Pulmonary Health Center 017/00000023/00000004/a
Semarang City, Indonesia rt00233
11 Soil-Transmitted Helminth Advanced Science 2017, 23, Pp 3565–3568
Infection in Elementary School Letter http://www.ingentaconnec
Children: An Integrated t.com/contentone/asp/asl/2
Environment and Behavior: 017/00000023/00000004/a
Case Study
District, in Bandungan
Semarang DistrictSub- rt00236
12 Factors associated with failure Advanced Science 2017, 23, Pp 3572–3575
of Conversion Among Letter http://www.ingentaconnec
Tuberculosis Patients t.com/contentone/asp/asl/2
017/00000023/00000004/a
13 Blood Glucose Profile Among Advanced Science 2017, 23, Pp 3614–3616
Adult Women in Semarang Letter http://www.ingentaconnec
t.com/contentone/asp/asl/2
017/00000023/00000004/a
14 A Mixed Method Study Of International Journal Of 2017, Vol 4 no 9
Tuberculosis Case Management Community Medicine http://www.ijcmph.com/in
In Hospitals Of West And And Public Health dex.php/ijcmph/article/vie
Central Java, Indonesia w/1782
15 Mapping Of Leptospirosis E3S Web of Conferences 2018, volume 31
Environmental Risk Factors and 31, 06003 (2018) https://doi.org/10.1051/e3s
Determining the Level of conf/20183106003
Leptospirosis Vulnerable Zone
In Demak District Using
Remote Sensing Image
16 The Presence Of Rat And House E3S Web of Conferences 2018, volume 31
Sanitation Associated With 31, 06008 (2018)
Leptospiras p. Bacterial https://doi.org/10.1051/e3s
Infection In Rats (A Cross conf/20183106008
Sectional Study In Semarang,
Central Java Province,
Indonesia)
17 Implementation of Water Safety IOP Conference Series: Volume 116, conference
Plans (WSPs): A Case Study in Earth and Environmental 1,\ 012029
the Coastal Area in Semarang Science doi :10.1088/1755-
City, Indonesia 1315/116/1/012029
18 Epidemiology of Child IOP Conference Series: Volume 116, conference
Tuberculosis (A Cross-Sectional Earth and Environmental 1, 012081
Study at Pulmonary Health Science doi :10.1088/1755-
Center Semarang City, 1315/116/1/012081
Indonesia)
19 Vaccines Cold Chain IOP Conference Series: Volume 116, conference
Monitoring: A Cross Sectional Earth and Environmental 1, 012082
Study at Three District In Science doi :10.1088/1755-
Indonesia 1315/116/1/012082
G.Penghargaandalam10tahunTerakhir(daripemerintah,asosiasiatauinstitusilainnya
No JenisPenghargaan InstitusiPemberi Tahun
Penghargaan
1 Dosen berprestasi UNDIP 2013
2 Runner Up Best Oral Presenter in UGM 2013
International symposium integrating
research and action on dengue
3 Best Oral Presenter in ICEOH UPM (Universiti Putra Jaya) 2016
Malaysia
4 Best Poster Presentation in International UNDIP 2016
Conference on Public Health for Tropical
and Coastal Development (ICOPH-TCD
2016)
5 Satya Lencana 10 tahun Presiden Republik Indonesia 2016
Semua data yang saya isikan dan tercantum dalam biodata ini adalah benar dan dapat
dipertanggungjawabkan secara hukum. Apabila di kemudian hari ternyata
dijumpai ketidak-sesuaian dengan kenyataan, saya sanggup menerima sanksi.
Demikian biodata ini saya buat dengan sebenarnya untuk memenuhi salah
satu persyaratan dalam pengajuan PDUPT 2018.
A. Identitas
1 Nama Lengkap Praba Ginandjar, SKM, M.Biomed
2 Jenis kelamin Perempuan
3 Jabatan fungsional Lektor Kepala
4 NIP 197109041997022004
5 NIDN 004097102
6 Tempat dan tanggal lahir Purbalingga, 4 September 1971
7 Email praba.ginandjar@live.undip.ac.id
8 Nomor HP 081325887942
9 Alamat kantor Jl. Prof. Sudarto SH, Kampus UNDIP Tembalang,
Semarang 50275
10 Nomor telepon 024-7460044
11 Lulusan yang telah S1: orang
dihasilkan S2: orang
12 Mata kuliah yang diampu 1. Dasar epidemiologi
2. Dasar biomedik 2
3. Vaksin imun
4. Penyakit tropik
5. Epidemiologi KIA
6. Penulisan ilmiah
7. Penyakit tular vektor
B. Riwayat pendidikan
S1 S2
Nama Perguruan Universitas Diponegoro Universitas Indonesia
Tinggi
Bidang Ilmu Epidemiologi Biomedik
Tahun Masuk-Lulus 1990-1995 2000-2003
Judul GAKI Deteksi IgG4 anti-filaria
Skripsi/Tesis/Disertasi dengan brugia rapid test pada
daerah endemis Brugia
malayi di Pulau Alor, NTT
Nama dr. R. Djoko Nugroho, Prof. Taniawati Supali, PhD
Pembimbing/Promotor M.Kes
Semua data yang saya isikan dan tercantum dalam biodata ini adalah benar dan dapat
dipertanggungjawabkan secara hukum. Apabila di kemudian hari ternyata dijumpai
ketidak-sesuaian dengan kenyataan, saya sanggup menerima sanksi.
Demikian biodata ini saya buat dengan sebenarnya untuk memenuhi salah satu
persyaratan dalam pengajuan PDUPT 2018.
2 Jenis Kelamin P
3 Jabatan Fungsional -
4. NIP 198910310117012076
5. NIDN 0731108901
7. Email nissakusariana@gmail.com
9. Alamat & No. Tlp/Faks. Jl. Prof. Sudarto, SH, Tembalang, Semarang
Kantor 024 7460044/ Fax.024 7460044 ext 102
3. Dasar Epidemiologi
4. Penyakit Tropik
6. Entomologi Kesehatan
7. Teknik Entomologi
B. Riwayat Pendidikan :
Keterangan S1 S2
Nama Perguruan Tinggi Universitas Diponegoro IPB
C. Riwayat Penelitian
No. Tahun Judul Penelitian Pendanaan
Sumber Jumlah
- - - - -
D. Riwayat Pengabdian
No Tahun Judul Pengabdian Kepada Masyarakat Pendanaan
. Sumber Jumlah
- - - - -
PERSONAL IDENTITY
Sex : FEMALE
Religion : MOSLEM
Citizenship : INDONESIAN
FORMAL EDUCATION
Year
Name of Institution Location Faculty/Majoring Result
In Out
MASTER OF
EPIDEMIOLOGY,
2018 SEMARANG EPIDEMIOLOGY ON GOING
POSTGRADUATE SCHOOL,
DIPONEGORO UNIVERSITY
PUBLIC HEALTH /
2010 2014 DIPONEGORO UNIVERSITY SEMARANG EPIDEMIOLOGY AND GRADUATED
TROPICAL DISEASE
2007 2010 SMA NEGERI 1 REMBANG REMBANG SCIENCE GRADUATED
SD NEGERI
1998 2004 REMBANG - GRADUATED
DOROKANDANG 1
SKILLS
GOOD IN TEAMWORK
SKILLS
MICROSOFT WINDOWS BASED OPERATING SYSTEM, MICROSOFT OFFICE (MS WORD, MS EXCEL,
POWER POINT)
FAMILIAR WITH FIRST AID
LANGUAGE
UNDERSTAND COMMUNICATION IN ENGLISH, BOTH ORAL AND WRITTEN
PROFICIENCY
ORGANIZATION EXPERIENCES
Seminary
Year Organizer / Institution
PARTICIPANT OF INTERNATIONAL SEMINARY UNDIP- PUBLIC HEALTH FACULTY OF
2017
TUFTS UNIVERSITY: ONE HEALTH AND ZOONOSIS DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE INTERNATIONAL SEMINARY PUBLIC HEALTH FACULTY OF
2013
UNDIP-UNIVERSITY OF QUEENSLAND JOINT SEMINAR DIPONEGORO UNIVERSITY
22013 : RESEARCH FOR POLICY COMMUNITY
HEALTH-INSIGHT FROM RESENT
PARTICIPANTS OF THE NATIONAL SEMINARY YOUNG ON
TOP ENTERPREUNERSHIP SEMINAR “SMART CHANGE IN 2012 BNI
YOUR LIFE”
PARTICIPANTS OF THE NATIONAL SEMINARY AND TALK
FACULTY OF MEDICINE DIPONEGORO
SHOW “ MAKING POSITIVE CHANGE, STRESS FREE FOR 2012
UNIVERSITY
HEALTHIER LIFE”
PARTICIPANTS OF THE NATIONAL SEMINARY “WORLD PUBLIC HEALTH FACULTY OF
2012
FIT FOR CHILDREN” DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE NATIONAL SEMINARY
2011 DIPONEGORO UNIVERSITY
“SCHOLARSHIP SHOW 2011”
PARTICIPANTS OF THE NATIONAL SEMINARY “SEHAT PUBLIC HEALTH FACULTY OF
2011
ISTRIKU, SEHAT IBUKU, INDONESIAKU” DIPONEGORO UNIVERSITY
PARTICIPANTS OF THE NATIONAL SEMINARY ON
OCCUPATIONAL AND SAFETY “THE APLICATION OF OSH
2011 OSH FORUM FKM UNDIP
PROFESSION IN INDUSTRY AND OSH CULTURE IN
CONSTRUCTION SERVICE”
TRAINING “DIKLATSAR KSR PMI UNIT FKM UNDIP” 2010 KSR UNIT FKM UNDIP
Data Pribadi
Nama Lengkap : Endang Sri Utami
Nama Panggilan : Endang
Tempat, Tanggal Lahir : Pemalang, 13 Mei 1994
Angkatan : 2013
Fakultas / Jurusan : Kesehatan Masyarakat
Jenis Kelamin : Perempuan
Golongan Darah : AB
Semester : VII
Alamat Asal : Jl. Salak No. 26 RT 03/I Kraton, Kota Tegal
Alamat Sekarang : Jl. Sumurboto 2 No 13 RT 05/03 Banyumanik, Semarang
No HP : 085712563613 / 085225695352
Alamat E-mail : endangsriutami13@gmail.com
Motto Hidup : Man Jadda Wa Jadda
Pendidikan Formal :
Sekolah – Universitas Tahun
Kesehatan Masyarakat – Universitas Diponegoro 2017
SMA Negeri 1 Kota Tegal 2013
SMP Negeri 7 Kota Tegal 2010
SD Negeri Tegalsari 8 Kota Tegal 2007
Organisasi dan Pengembangan Softskill yang Pernah Di Ikuti:
Lembaga Departemen Jabatan Tahun
Penalaran Ilmiah Research
Club (PIRC) FKM Non Divisi Direktur 2016
Humas (Supporting
FKM Undip Wadek 4 FKM Undip) Tim 2016
Penalaran Ilmiah Research
Club (PIRC) FKM Edukasi Manager 2015
Penalaran Ilmiah Research
Club (PIRC) FKM Edukasi Staf Muda 2014
Keluarga Mahasiswa Islam
(Gamais) FKM Humas Staf Muda 2014
Pelatihan dan Seminar yang Pernah di Ikuti
Prestasi yang Pernah Diraih :
Nama Lomba/Event Penyelenggara Urutan Tahun
Public Health Paper Competition FKM UNDIP Juara 3 2015
Hibah Penelitian Mahasiswa UNDIP Lolos didanai 2015
Inovation Engineering Society ITS Finalis 5 Besar 2015
Hibah Pemberdayaan dan MITI Lolos didanai 2015
Pengabdian Masyarakat
Hibah Penelitian Mahasiswa UNDIP Lolos didanai 2014
Kepanitiaan Yang Pernah di Ikuti